Association of DNA Methylation–Derived C‐Reactive Protein Predictors With All‐Cause Mortality and Blood Lipids in Adults Aged ≥ 50 Years in the United States
Lipids · 2026-07 · 61 (4) · 467-478
DOI: 10.1002/lipd.70046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lipids, online erschienen am 01.03.2026. Verfasst von Yu Yan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: C-Reactive Protein, DNA Methylation, Lipids, Cardiovascular Diseases. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Chronic low‐grade inflammation contributes to aging, metabolic dysfunction, and age‐related diseases. High‐sensitivity C‐reactive protein (HsCRP) is widely used but limited by short‐term variability. DNA methylation–based CRPMort derived from GrimAge2 may provide a more stable measure of chronic inflammatory burden, yet its predictive value for mortality and association with lipid metabolism remain unclear. Associations of CRPMort and HsCRP with all‐cause and cardiovascular mortality and lipid traits were evaluated using weighted cox regression and linear regression, Kaplan–Meier curves, restricted cubic splines (RCS), and time‐dependent receiver operating characteristic curve (timeROC) analyses within the NHANES database, with subgroup, mediation, sensitivity, and Mendelian randomization analyses. Higher CRPMort was significantly associated with all‐cause mortality (hazard ratio [95% confidence interval]: 1.65 [1.10, 2.46], p = 0.015) and showed near‐significant positive associations with triglycerides ( p = 0.051) and residual cholesterol ( p = 0.056). RCS analyses demonstrated a linear positive relationship between CRPMort and both all‐cause mortality and lipid traits, including triglycerides and residual cholesterol. HsCRP showed no significant associations with mortality or lipid traits (all p > 0.05). TimeROC curves revealed that compared to HsCRP, CRPMort had more superior long‐term predictive performance and partially mediated the effect of chronological age on all‐cause mortality. Importantly, concurrent elevations of CRPMort and HsCRP were associated with the highest risks of all‐cause mortality and dyslipidemia. GrimAge2‐derived CRPMort is a robust predictor of long‐term all‐cause mortality and may capture chronic inflammation linked to triglyceride‐rich lipoproteins beyond HsCRP. Combined assessment of both inflammatory markers may enhance risk stratification and inform aging‐related cardiometabolic research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Yan, Y., Gong, Z., & Ma, S. (2026). Association of DNA Methylation–Derived C‐Reactive Protein Predictors With All‐Cause Mortality and Blood Lipids in Adults Aged ≥ 50 Years in the United States. Lipids, 61(4), 467-478. https://doi.org/10.1002/lipd.70046
Vancouver
Yan Y, Gong Z, Ma S. Association of DNA Methylation–Derived C‐Reactive Protein Predictors With All‐Cause Mortality and Blood Lipids in Adults Aged ≥ 50 Years in the United States. Lipids. 2026;61(4):467-478. doi:10.1002/lipd.70046
BibTeX
@article{Yan2026,
author = {Yan, Yu and Gong, Zhipeng and Ma, Shuangliang},
title = {Association of DNA Methylation–Derived C‐Reactive Protein Predictors With All‐Cause Mortality and Blood Lipids in Adults Aged ≥ 50 Years in the United States},
journal = {Lipids},
year = {2026},
volume = {61},
number = {4},
pages = {467--478},
doi = {10.1002/lipd.70046}
}
EUVIMED